Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1640 | In-person postoperative visit Wiki | 1.00 |
drug884 | Convalescent Plasma Wiki | 0.19 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
D018352 | Coronavirus Infections NIH | 0.03 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this clinical study is to evaluate whether remote video/audio postoperative visits (telemedicine visits) affects patient satisfaction compared to in-person visits during the COVID-19 pandemic. If the primary objective of the study is achieved, it would allow better understanding of how telemedicine can be integrated into modern surgical practice to take care of postoperative patients.
Description: Patient satisfaction score measured by electronic survey sent to all participating patients after their first postoperative visit
Measure: Patient satisfaction Time: 7 to 14 days postoperativelyDescription: Patient-reported safety score rated from 1 to 5
Measure: Safety score Time: 7 to 14 days postoperativelyDescription: Length of postoperative visit
Measure: Length of visit Time: 7 to 14 days postoperativelyDescription: Patient willingness to recommend provider to peers rated from 1 to 5
Measure: Patient willingness to recommend provider to peers rated from 1 to 5 Time: 7 to 14 days postoperativelyDescription: Combined patient satisfaction score from 1st and 2nd postoperative visits
Measure: Combined patient satisfaction score from 1st and 2nd postoperative visits Time: 7 to 31 days postoperativelyDescription: Distance (in kilometers) of patient's primary residence to the clinic location
Measure: Distance (in kilometers) of patient's primary residence to the clinic location Time: 7 to 31 days postoperativelyAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports